EPISODE · Oct 23, 2025 · 2 MIN
ACT Brief: AI Innovations, Vision Trial Breakthroughs, and a Major Industry Acquisition
from Applied Clinical Trials · host Applied Clinical Trials
In today’s ACT Brief, we revisit key insights from SCOPE Summit 2025 on AI and pragmatic trials, examine Genentech’s Phase III vamikibart data in uveitic macular edema, and highlight MJH Life Sciences’ acquisition of BPD Healthcare—expanding the bridge from discovery to delivery.
Embed this episode
Ready to play
ACT Brief: AI Innovations, Vision Trial Breakthroughs, and a Major Industry Acquisition
0:00
2:32
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Applied Clinical Trials?
This episode is 2 minutes long.
When was this Applied Clinical Trials episode published?
This episode was published on October 23, 2025.
Can I download this Applied Clinical Trials episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!